Global Decentralized Clinical Trials (DCTs) Market valued at $8.8 billion (2021), is set to witness a healthy growth rate of 10% to reach $14.2 billion by 2026. Benefits of DCTs, Covid-19, growing adoption by pharmaceutical, medical device companies & contract research organizations (CROs), formation of industry stakeholder groups such as Decentralized Trials & Research Alliance (DTRA) to facilitate collaboration and research, favorable funding & regulatory outlook, and surge in M&A activities are some of the key factors driving the decentralized clinical trials market growth. However, concerns around patient data privacy are likely to hamper the growth of the market. Decentralized clinical trials (DCT) employ a method of conducting clinical trials where parts or all of the trial happen outside a traditional physical clinic or trial site. Clinical trial studies are conducted via telemedicine, mobile/local healthcare providers & digital/mobile technologies...
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip Investors & hyper-growth Start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy.